Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic linagliptin + metformin vs Trajenta Duo under fed conditions in healthy Thai volunteers
TCTR20231012008Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of linagliptin + metformin, linagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
linagliptin + metforminlinagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20231012008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231012008.